Clinical trial
Serum Epstein-Barr Virus-induced Gene 3 Protein Levels in Patients With Behçet's Disease
NCT07845162 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Serum Epstein-Barr Virus-induced Gene 3 Protein Levels in Patients With Behçet's Disease
- Lead sponsor
- Assiut University
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- September 26, 2026
- Completion date
- January 25, 2028
- Enrollment
- 90 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
behçet disease